New Possibilities for Maintenance Therapy in AML

TARGET AUDIENCE:
This activity is intended for hematologists/oncologists and hematology nurse practitioners, physician assistants and other members of the multidisciplinary care team who treat patients with AML.
PROGRAM OVERVIEW:
The role of maintenance treatment in AML care has significantly transformed in recent times; as a result, patients now have more options and less relapse should occur. However, due to the volume and complexity of information that has recently emerged, clinicians may be challenged to keep abreast of the latest developments surrounding maintenance care in AML. To provide optimal patient care, clinicians must be prepared with a comprehensive understanding of the latest developments that could significantly impact patient outcomes.
LEARNING OBJECTIVES:
Upon completion of this activity, participants will be able to:
• Discuss predictive factors that contribute to patient relapse in acute myeloid leukemia (AML).
• Analyze recent clinical trial data of new and emerging therapies for AML in the maintenance setting.
• Formulate collaborative strategies and shared decision-making (SDM) practices to ensure patient engagement in treatment decisions regarding AML care.